Literature DB >> 20855477

Management of patients with acute hyperkalemia.

Meghan J Elliott1, Paul E Ronksley, Catherine M Clase, Sofia B Ahmed, Brenda R Hemmelgarn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20855477      PMCID： PMC2952010          DOI： 10.1503/cmaj.100461

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  32 in total

1.  A randomized controlled trial of fludrocortisone for the treatment of hyperkalemia in hemodialysis patients.

Authors:  Mohammed O Kaisar; Kathryn J Wiggins; Joanne M Sturtevant; Carmel M Hawley; Scott B Campbell; Nicole M Isbel; David W Mudge; Andrew Bofinger; James J B Petrie; David W Johnson
Journal:  Am J Kidney Dis       Date:  2006-05       Impact factor: 8.860

2.  Risk factors associated with a high velocity of the development of hyperkalaemia in hospitalised patients.

Authors:  Jörg Indermitte; Sabine Burkolter; Jürgen Drewe; Stephan Krähenbühl; Kurt E Hersberger
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

3.  Hyperkalemia in hospitalized patients: causes, adequacy of treatment, and results of an attempt to improve physician compliance with published therapy guidelines.

Authors:  C G Acker; J P Johnson; P M Palevsky; A Greenberg
Journal:  Arch Intern Med       Date:  1998-04-27

Review 4.  Emergency interventions for hyperkalaemia.

Authors:  B A Mahoney; W A D Smith; D S Lo; K Tsoi; M Tonelli; C M Clase
Journal:  Cochrane Database Syst Rev       Date:  2005-04-18

5.  The faster potassium-lowering effect of high dialysate bicarbonate concentrations in chronic haemodialysis patients.

Authors:  Ricardo M Heguilén; Claudia Sciurano; Angel D Bellusci; Paula Fried; Graciela Mittelman; Guillermo Rosa Diez; Amelia R Bernasconi
Journal:  Nephrol Dial Transplant       Date:  2005-02-01       Impact factor: 5.992

6.  The efficiency of potassium removal during bicarbonate hemodialysis.

Authors:  M Capdevila; I Martinez Ruiz; C Ferrer; F Monllor; C Ludjvick; N H García; L I Juncos
Journal:  Hemodial Int       Date:  2005-07       Impact factor: 1.812

Review 7.  Potassium disorders--clinical spectrum and emergency management.

Authors:  Annette V M Alfonzo; Chris Isles; Colin Geddes; Chris Deighan
Journal:  Resuscitation       Date:  2006-04-04       Impact factor: 5.262

8.  Effect of single dose resin-cathartic therapy on serum potassium concentration in patients with end-stage renal disease.

Authors:  C Gruy-Kapral; M Emmett; C A Santa Ana; J L Porter; J S Fordtran; K D Fine
Journal:  J Am Soc Nephrol       Date:  1998-10       Impact factor: 10.121

9.  Effect of fludrocortisone acetate on reducing serum potassium levels in patients with end-stage renal disease undergoing haemodialysis.

Authors:  Dong-Min Kim; Jong Hoon Chung; Sung Ho Yoon; Hyun Lee Kim
Journal:  Nephrol Dial Transplant       Date:  2007-07-05       Impact factor: 5.992

10.  Effects of presentation and electrocardiogram on time to treatment of hyperkalemia.

Authors:  Kalev Freeman; James A Feldman; Patricia Mitchell; Jacqueline Donovan; K Sophia Dyer; Laura Eliseo; Laura Forsberg White; Elizabeth S Temin
Journal:  Acad Emerg Med       Date:  2008-03       Impact factor: 3.451
View more
  18 in total

Review 1.  Spontaneous tumour lysis syndrome.

Authors:  Natasha Kekre; Bojana Djordjevic; Claire Touchie
Journal:  CMAJ       Date:  2012-04-10       Impact factor: 8.262

Review 2.  [Safe treatment of acute hyperkalemia : The 1:4 and other principles].

Authors:  P Groene; G Hoffmann
Journal:  Anaesthesist       Date:  2017-06       Impact factor: 1.041

Review 3.  Tumor lysis syndrome and primary hepatic malignancy: case presentation and review of the literature.

Authors:  Sean P Zivin; Youssef Elias; Charles E Ray
Journal:  Semin Intervent Radiol       Date:  2015-03       Impact factor: 1.513

4.  Runner's new diet, his collapse, and his ECG: when a rapid ECG diagnosis can save the day.

Authors:  Melissa Ringer; Simon Pulfrey
Journal:  Can Fam Physician       Date:  2014-04       Impact factor: 3.275

5.  Association between Serum Potassium and Outcomes in Patients with Reduced Kidney Function.

Authors:  Jiacong Luo; Steven M Brunelli; Donna E Jensen; Alex Yang
Journal:  Clin J Am Soc Nephrol       Date:  2015-10-23       Impact factor: 8.237

6.  Impact of dextrose dose on hypoglycemia development following treatment of hyperkalemia.

Authors:  Nicholas Farina; Christopher Anderson
Journal:  Ther Adv Drug Saf       Date:  2018-04-11

7.  Hyperkalemia among hospitalized patients and association between duration of hyperkalemia and outcomes.

Authors:  Jagadish Khanagavi; Tanush Gupta; Wilbert S Aronow; Tushar Shah; Jalaj Garg; Chul Ahn; Sachin Sule; Stephen Peterson
Journal:  Arch Med Sci       Date:  2014-05-13       Impact factor: 3.318

8.  Characterization of structure and function of ZS-9, a K+ selective ion trap.

Authors:  Fiona Stavros; Alex Yang; Alejandro Leon; Mark Nuttall; Henrik S Rasmussen
Journal:  PLoS One       Date:  2014-12-22       Impact factor: 3.240

9.  Validity of the International Classification of Diseases 10th revision code for hyperkalaemia in elderly patients at presentation to an emergency department and at hospital admission.

Authors:  Jamie L Fleet; Salimah Z Shariff; Sonja Gandhi; Matthew A Weir; Arsh K Jain; Amit X Garg
Journal:  BMJ Open       Date:  2012-12-28       Impact factor: 2.692

10.  Pharmacokinetics and safety of olodaterol administered with the Respimat Soft Mist inhaler in subjects with impaired hepatic or renal function.

Authors:  Christina Kunz; Doreen Luedtke; Anna Unseld; Alan Hamilton; Atef Halabi; Martina Wein; Stephan Formella
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-03-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.